$NVAX

Novavax Inc

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Gaithersburg, MD

NVAX chart

What traders are saying about $NVAX

Latest posts

Novavax Inc news

Novavax Inc key financials

USD2025202420232022
Revenue$1.12B$682.2M$983.7M$1.98B
Net income$440.3M-$187.5M-$545.1M-$657.9M
Diluted EPS$2.58$-1.23$-5.41$-8.42
Total assets (year end)$1.18B$1.56B$1.80B$2.26B
Cash and equivalents (year end)$240.6M$530.2M$568.5M$1.34B

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Novavax Inc

Ticker
NVAX (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Gaithersburg, MD
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1000694

Frequently asked questions

What exchange is Novavax Inc listed on?

Novavax Inc trades on the Nasdaq under the ticker symbol NVAX.

What industry is Novavax Inc in?

Novavax Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Novavax Inc headquartered?

Novavax Inc's business address on file with the SEC is in Gaithersburg, MD.

When does Novavax Inc's fiscal year end?

Novavax Inc's fiscal year ends on December 31.

How much revenue did Novavax Inc report?

Novavax Inc reported $1.12B in revenue for calendar year 2025, according to its SEC filings.